↓ Skip to main content

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials

Overview of attention for article published in Frontiers in Pharmacology, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials
Published in
Frontiers in Pharmacology, January 2020
DOI 10.3389/fphar.2019.01577
Pubmed ID
Authors

Bixi Gao, Yanbo Yang, Zilan Wang, Yue Sun, Zhouqing Chen, Yun Zhu, Zhong Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 13%
Student > Bachelor 7 10%
Other 6 8%
Student > Master 6 8%
Student > Postgraduate 4 6%
Other 9 13%
Unknown 31 43%
Readers by discipline Count As %
Medicine and Dentistry 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 8 11%
Neuroscience 8 11%
Biochemistry, Genetics and Molecular Biology 3 4%
Nursing and Health Professions 3 4%
Other 4 6%
Unknown 35 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#3,363,266
of 25,874,560 outputs
Outputs from Frontiers in Pharmacology
#1,504
of 20,034 outputs
Outputs of similar age
#78,546
of 478,118 outputs
Outputs of similar age from Frontiers in Pharmacology
#46
of 428 outputs
Altmetric has tracked 25,874,560 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,034 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 478,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 428 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.